Similarly, co-treatment with PD-1 mAb and sheEF2K further decreased the tumor volume and tumor weight compared with sheEF2K or PD-1 mAb alone treatment, and CD8α blockade rescued the decreased tumor growth induced by this combination (figure 8G–I, online supplemental figure S6C). This evidence concerns the gene PDCD1 and neoplasm.